Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Is early percutaneous coronary intervention safe in patients ACS and cancer?

Autor: Scarpone, M, Bergami, M, Cenko, E, Vasiljevic, Z, Zdravkovic, M, Vavlukis, M, Kedev, S, Milicic, D, Manfrini, O, Bugiardini, R

Publikováno v: European Heart Journal. 42

Background Patients with malignancies may have a high pro-thrombotic status as well as a high risk of hemorrhagic events either due to the tumor or its treatment. For this reason, these patients have always been excluded from randomized clinical tria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb68f1f5a42d6c1201172453fab4a61
https://doi.org/10.1093/eurheartj/ehab724.2885

Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome

Autor: Bugiardini, R, Yoon, J, Mendieta, G, Kedev, S, Zdravkovic, M, Vasiljevic, Z, Milicic, D, Manfrini, O, van der Schaar, M, Gale, CP, Bergami, M, Badimon, L, Cenko, E

Publikováno v: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

BACKGROUND There is uncertainty regarding the impact of statins on the risk of atherosclerotic cardiovascular disease (ASCVD) and its major complication, acute heart failure (AHF). OBJECTIVES The aim of this study was to investigate whether previous

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::651b3930154777b6556a899a3712653f
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13067

IS A FAMILY HISTORY OF CORONARY HEART DISEASE AN INDEPENDENT CARDIOVASCULAR RISK FACTOR?

Autor: Simovic, S, Davidovic, G, Yoon, J, Kedev, S, Zdravkovic, M, Vasiljevic, Z, Milicic, D, Manfrini, O, van der Schaar, M, Gale, CP, Bergami, M, Badimon, L, Cenko, E, Bugiardini, R

Publikováno v: Journal of the American College of Cardiology. 79:1073

Background: Although a family history (FHx) is an accepted risk factor for cardiovascular (CV) disease, few studies have examined the predictive strength of a positive FHx after adjusting for other conventional risk factors and medications Methods: W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7625f875e1910667c7f51532033f540
https://doi.org/10.1016/s0735-1097(22)02064-2

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.